These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 18338406)

  • 21. Tamoxifen and genistein synergistically down-regulate signal transduction and proliferation in estrogen receptor-negative human breast carcinoma MDA-MB-435 cells.
    Shen F; Xue X; Weber G
    Anticancer Res; 1999; 19(3A):1657-62. PubMed ID: 10470097
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Modulation of epirubicin cytotoxicity by tamoxifen in human breast cancer cell lines.
    Azab SS; El-Demerdash E; Abdel-Naim AB; Youssef E; El-Sharkawy N; Osman AM
    Biochem Pharmacol; 2005 Sep; 70(5):725-32. PubMed ID: 16005435
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synergistic cytotoxic effects of tumor necrosis factor, interferon-gamma and tamoxifen on breast cancer cell lines.
    Matsuo S; Takano S; Yamashita J; Ogawa M
    Anticancer Res; 1992; 12(5):1575-9. PubMed ID: 1444224
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Biotransformation of melatonin in human breast cancer cell lines: role of sulfotransferase 1A1.
    Aust S; Jaeger W; Klimpfinger M; Mayer K; Baravalle G; Ekmekcioglu C; Thalhammer T
    J Pineal Res; 2005 Oct; 39(3):276-82. PubMed ID: 16150108
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sequence-dependent antagonism between tamoxifen and methotrexate in human breast cancer cells.
    Bowen D; Southerland WM; Hawkins M; Johnson DH
    Anticancer Res; 2000; 20(3A):1415-7. PubMed ID: 10928050
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Troglitazone enhances tamoxifen-induced growth inhibitory activity of MCF-7 cells.
    Yu HN; Noh EM; Lee YR; Roh SG; Song EK; Han MK; Lee YC; Shim IK; Lee SJ; Jung SH; Kim JS; Youn HJ
    Biochem Biophys Res Commun; 2008 Dec; 377(1):242-7. PubMed ID: 18835379
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effect of quercetin on topotecan cytotoxicity in MCF-7 and MDA-MB 231 human breast cancer cells.
    Akbas SH; Timur M; Ozben T
    J Surg Res; 2005 May; 125(1):49-55. PubMed ID: 15836850
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The regulatory effect of tamoxifen on fibronectin expression in estrogen-dependent MCF-7 breast carcinoma cells.
    Horii Y; Takei H; Koibuchi Y; Horiguchi J; Maemura M; Iino Y; Morishita Y
    Oncol Rep; 2006 May; 15(5):1191-5. PubMed ID: 16596185
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vitro and in vivo anti-angiogenic activities and inhibition of hormone-dependent and -independent breast cancer cells by ceramide methylaminoethylphosphonate.
    Chintalapati M; Truax R; Stout R; Portier R; Losso JN
    J Agric Food Chem; 2009 Jun; 57(12):5201-10. PubMed ID: 19476359
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [The inhibiting effect of genistein on the growth of human breast cancer cells in vitro].
    He FJ; Wang J; Niu JZ; Wang JF
    Zhongguo Zhong Yao Za Zhi; 2002 Dec; 27(12):936-9. PubMed ID: 12776537
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Synergistic anti-cancer effects of silibinin with conventional cytotoxic agents doxorubicin, cisplatin and carboplatin against human breast carcinoma MCF-7 and MDA-MB468 cells.
    Tyagi AK; Agarwal C; Chan DC; Agarwal R
    Oncol Rep; 2004 Feb; 11(2):493-9. PubMed ID: 14719089
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inhibition of human breast cancer cell proliferation with estradiol metabolites is as effective as with tamoxifen.
    Seeger H; Huober J; Wallwiener D; Mueck AO
    Horm Metab Res; 2004 May; 36(5):277-80. PubMed ID: 15156405
    [TBL] [Abstract][Full Text] [Related]  

  • 33. AP-1 blockade inhibits the growth of normal and malignant breast cells.
    Ludes-Meyers JH; Liu Y; Muñoz-Medellin D; Hilsenbeck SG; Brown PH
    Oncogene; 2001 May; 20(22):2771-80. PubMed ID: 11420689
    [TBL] [Abstract][Full Text] [Related]  

  • 34. 13-cis retinoic acid and all-trans retinoic acid in the regulation of the proliferation and survival of human breast cancer cell line MCF-7.
    Czeczuga-Semeniuk E; Wolczyński S; Dziecioł J; Dabrowska M; Anchim T; Tomaszewska I
    Cell Mol Biol Lett; 2001; 6(4):925-39. PubMed ID: 11753438
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of tamoxifen on telomerase activity in breast carcinoma cell lines.
    Aldous WK; Marean AJ; DeHart MJ; Matej LA; Moore KH
    Cancer; 1999 Apr; 85(7):1523-9. PubMed ID: 10193942
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Additive antitumor effect of concurrent treatment of 4-hydroxy tamoxifen with 5-fluorouracil but not with doxorubicin in estrogen receptor-positive breast cancer cells.
    Kurebayashi J; Nukatsuka M; Nagase H; Nomura T; Hirono M; Yamamoto Y; Sugimoto Y; Oka T; Sonoo H
    Cancer Chemother Pharmacol; 2007 Mar; 59(4):515-25. PubMed ID: 16900372
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Combined effects of tamoxifen and a chimeric humanized single chain antibody against the type I IGF receptor on breast tumor growth in vivo.
    Ye JJ; Liang SJ; Guo N; Li SL; Wu AM; Giannini S; Sachdev D; Yee D; Brünner N; Ikle D; Fujita-Yamaguchi Y
    Horm Metab Res; 2003; 35(11-12):836-42. PubMed ID: 14710366
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Direct antiproliferative effect of triptorelin on human breast cancer cells.
    Marini L; Iacopino F; Schinzari G; Robustelli della Cuna FS; Mantovani G; Sica G
    Anticancer Res; 1994; 14(5A):1881-5. PubMed ID: 7847821
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The DNA-damaging potential of tamoxifen in breast cancer and normal cells.
    Wozniak K; Kolacinska A; Blasinska-Morawiec M; Morawiec-Bajda A; Morawiec Z; Zadrozny M; Blasiak J
    Arch Toxicol; 2007 Jul; 81(7):519-27. PubMed ID: 17593413
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Synergistic cytotoxic effects of tamoxifen and black cohosh on MCF-7 and MDA-MB-231 human breast cancer cells: an in vitro study.
    Al-Akoum M; Dodin S; Akoum A
    Can J Physiol Pharmacol; 2007 Nov; 85(11):1153-9. PubMed ID: 18066117
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.